NeoGenomics, Inc. Capitalized Contract Cost, Net, Current
NeoGenomics, Inc. (NEO) had Capitalized Contract Cost, Net, Current of $234.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CapitalizedContractCostNetCurrent · last filed 2026-07-28
- 2026-06-30: Capitalized Contract Cost, Net, Current $234.00K.
- 2026-03-31: Capitalized Contract Cost, Net, Current $175.00K.
- 2025-12-31: Capitalized Contract Cost, Net, Current $138.00K.
- 2025-09-30: Capitalized Contract Cost, Net, Current $179.00K.
| Period end | Capitalized Contract Cost, Net, Current |
|---|---|
| 2026-06-30 | $234.00K 10-Q · filed 2026-07-28 |
| 2026-03-31 | $175.00K 10-Q · filed 2026-04-28 |
| 2025-12-31 | $138.00K 10-Q · filed 2026-07-28 |
| 2025-09-30 | $179.00K 10-Q · filed 2025-10-28 |
| 2025-06-30 | $199.00K 10-Q · filed 2025-07-29 |
| 2025-03-31 | $219.00K 10-Q · filed 2025-04-29 |
| 2024-12-31 | $206.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | $413.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $711.00K 10-Q · filed 2024-07-30 |
| 2024-03-31 | $810.00K 10-Q · filed 2024-04-30 |
| 2023-12-31 | $935.00K 10-K · filed 2025-02-18 |
| 2023-09-30 | $937.00K 10-Q · filed 2023-11-06 |
| 2023-06-30 | $923.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $912.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $800.00K 10-K · filed 2024-02-20 |
| 2022-09-30 | $106.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $128.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $168.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $109.00K 10-K · filed 2023-02-24 |
| 2021-09-30 | $126.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $128.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $182.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $185.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $160.00K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $183.00K 10-Q · filed 2020-07-31 |
| 2020-03-31 | $141.00K 10-Q · filed 2020-04-29 |
| 2019-12-31 | $133.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $222.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $254.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $310.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $271.00K 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |